Navigation Links
Researchers Identify Genes Tied to Breast Cancer that Spreads to the Brain

Chicago (PRWEB) September 20, 2013

Researchers have identified the epigenetic markers that determine whether breast cancer will spread to the brain, which could lead to earlier diagnoses and more effective treatment, suggests a study being presented today at ASCP 2013 Chicago, the annual meeting of the American Society for Clinical Pathology.

Breast cancer is the leading cause of cancer and the second most common cause of cancer death among U.S. women, according to the Centers for Disease Control and Prevention (CDC). Some breast cancers are more likely to spread beyond the breast (metastasize), including to the brain. Currently, doctors don’t have a clear picture at diagnosis regarding which breast cancers are likely to metastasize to the brain and which are not. Encouragingly, researchers have recently identified molecular markers called micro ribonucleic acids (RNAs) as potentially playing a role.

“Survival rates are low once breast cancer metastasizes to the brain,” said Seema Sethi, MD, a resident at Wayne State University and Detroit Medical Center, and lead author of the study. “This research will help us develop targeted therapies so we can more aggressively treat patients with this form of breast cancer.”

Researchers extracted micro RNA from the tumors of 90 women with breast cancer, including 45 whose cancer had spread to the brain (metastasized) and 45 whose cancer had not. After analyzing the data, researchers found that several micro RNAs were significantly altered in patients whose breast cancer had spread to the brain. They also identified several target genes involved in the process.

Researchers believe these micro RNAs and their target genes could help identify which breast cancers eventually will metastasize to the brain when the cancer is first diagnosed and determine the course of therapy, including how aggressive treatment should be. This newer approach, called personalized medicine, means targeted therapies and specific treatment options would be available depending on each patient’s medical history and epigenetic markers.

# # # # #

ASCP 2013 Chicago will be held at the Hyatt Regency Chicago, 151 E. Upper Wacker Dr., in Chicago. For more information about the meeting, visit

About the American Society for Clinical Pathology
Founded in 1922 in Chicago, ASCP is a medical professional society with more than 100,000 member board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students. ASCP provides excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UC Davis Researchers Find How Viral Infection Disrupts Neural Development in Offspring, Increasing Risk of Autism
2. IOActive Ramps Up Recruitment for Top Security Researchers and Consultants in South America
3. UI researchers: Bracing is effective in adolescents with idiopathic scoliosis
4. CWRU researchers find what stresses parents with a chronically ill child
5. Yale researchers see decline in hospitalizations for serious heart infection
6. Researchers identify novel biomarker for diabetes risk
7. Tufts researchers identify how Yersinia spreads within infected organs
8. Approved cancer drug potentially could help treat diabetes, Stanford researchers find
9. Mount Sinai Researchers Show Stem Cells Are Wired for Cooperation, Down to the DNA
10. Virginia Tech Carilion researchers find surprising relationships in brain signaling
11. Researchers to identify genetic biomarkers for aggressive breast cancer
Post Your Comments:
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology: